Literature DB >> 17138508

Patients' evaluation of the appropriateness of their hypertension management--a qualitative study.

Charles Morecroft1, Judy Cantrill, Mary P Tully.   

Abstract

BACKGROUND: The existing appropriateness measures for prescribing used in the United States and the United Kingdom use clinical attributes. Treatment and care from a patient's perspective need to be evaluated in terms of whether they are more likely to lead to an outcome of a life worth living, in social, psychological, and physical terms. However, it is unclear whether patients specifically evaluate their prescribed medication and treatment. If so, do they use only clinical attributes or a combination of clinical and nonclinical attributes?
OBJECTIVES: The aim of this study was to explore if patients evaluated their hypertension management, and if they did, investigate what attributes were involved in the evaluation.
METHODS: Semistructured interviews, which focused on personal experiences of hypertension and its management were undertaken with patients (n=28). The aim of the interviews was to obtain, in a narrative format, the experiences, beliefs, and information that patients considered important when discussing the management of hypertension. Data analysis used a constant comparative method.
RESULTS: All patients considered their hypertension management regimen appropriate, but were able to mention only 2 categories of attributes to justify their decision (the relationship with their General Practitioner and lowering of their blood pressure). Further series attributes were mentioned by the patient during the course of their interview; these attributes were considered to be involved in their evaluation. These implicit attributes were categorized as anxieties and concerns regarding treatment and diagnosis, explanation of the consequences of treatment, choice of antihypertensives, and the side effects experienced.
CONCLUSIONS: Patient's evaluation of appropriateness was constructed from both explicit and implicit attributes. Implicit attributes, those not consciously known to the patient still, could be involved in the process of evaluating hypertension, its treatment, and care. Although the nonmedical attributes that are considered by patients can be categorized, it has to be remembered that it is the inherent meaning held by each individual patient involved when an evaluation is made.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17138508     DOI: 10.1016/j.sapharm.2006.02.006

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  5 in total

1.  Measuring the impact of long-term medicines use from the patient perspective.

Authors:  Janet Krska; Charles W Morecroft; Philip H Rowe; Helen Poole
Journal:  Int J Clin Pharm       Date:  2014-07-05

Review 2.  Patient barriers to and enablers of deprescribing: a systematic review.

Authors:  Emily Reeve; Josephine To; Ivanka Hendrix; Sepehr Shakib; Michael S Roberts; Michael D Wiese
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

3.  Patients' views about taking a polypill to manage cardiovascular risk: a qualitative study in primary care.

Authors:  Satnam K Virdee; Sheila M Greenfield; Kate Fletcher; Richard J McManus; Jonathan Mant
Journal:  Br J Gen Pract       Date:  2015-06-15       Impact factor: 5.386

Review 4.  Lay perspectives on hypertension and drug adherence: systematic review of qualitative research.

Authors:  Iain J Marshall; Charles D A Wolfe; Christopher McKevitt
Journal:  BMJ       Date:  2012-07-09

5.  Structural equation modeling of the proximal-distal continuum of adherence drivers.

Authors:  Colleen A McHorney; Ning Jackie Zhang; Timothy Stump; Xiaoquan Zhao
Journal:  Patient Prefer Adherence       Date:  2012-11-09       Impact factor: 2.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.